RT Journal Article
SR Electronic
T1 Determinants of and barriers to adoption of digital therapeutics for mental health at scale in the NHS
JF BMJ Innovations
JO BMJ Innov
FD All India Institute of Medical Sciences
SP 92
OP 98
DO 10.1136/bmjinnov-2019-000384
VO 6
IS 3
A1 Matt G Williams
A1 Richard Stott
A1 Nicki Bromwich
A1 Susie K Oblak
A1 Colin A Espie
A1 James B Rose
YR 2020
UL http://innovations.bmj.com/content/6/3/92.abstract
AB Objectives Although it is widely acknowledged that digital therapeutics will play a significant role in the future delivery of healthcare, the method by which these innovations may be commissioned by the National Health Service, at scale, remains unclear. This study explores English health commissioners’ experiences of, and attitudes towards, adopting digital healthcare innovations.Methods 37 commissioners and decision-makers from a range of sectors within the health profession were invited to participate in structured interviews to gather relevant examples of experience and opinions. 14 commissioners participated and the notes from the resulting interviews were interpreted using qualitative content analysis. Controlled interpretation was applied to the categorised responses, paraphrasing and classifying into themes.Results Common determinants and barriers to adoption of digital mental health expressed during the interview process included commissioners’ lack of familiarity with technology, information governance, digital literacy of users and decision-makers.Conclusions Recognition of identified barriers may be helpful for innovators when developing engagement and market access strategies and suggest areas for focus and further development within the commissioning process to accommodate digital health solutions.